Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2019-10, Vol.19 (10), p.e288-e289
Main Authors: Chan, Wei Yee, Counsell, Nicholas, Popat, Rakesh, De Tute, Ruth, De-silva, Dunnya, Phillips, Elizabeth, Cavenagh, Jamie, Adedayo, Toyin, Braganca, Nivette, Roddie, Claire, Streetly, Matthew, Schey, Steve, Koh, Mickey, Crowe, Josephine, Quinn, Michael, Morris, Curly, D'Sa, Shirley, Virchis, Andres, Cook, Gordon, Crawley, Charles, Pratt, Guy, Cook, Mark, Clifton-Hadley, Laura, Rabin, Neil, Owen, Roger, Yong, Kwee
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
DOI:10.1016/j.clml.2019.09.475